Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 230Lymphoma 229Lymphoma, Non-Hodgkin 198Leukemia, Lymphocytic, Chronic, B-Cell 180Lymphoma, Large B-Cell, Diffuse 173Lymphoma, Follicular 170Lymphoma, B-Cell 111Lymphoma, Mantle-Cell 105Hodgkin Disease 102Recurrence 97Leukemia, Myeloid, Acute 95Multiple Myeloma 91Burkitt Lymphoma 89Leukemia 78Neoplasms 67Hematologic Neoplasms 61Lymphoma, B-Cell, Marginal Zone 58Myelodysplastic Syndromes 54Waldenstrom Macroglobulinemia 42Lymphoma, T-Cell 42Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 38Lymphoma, T-Cell, Peripheral 36Lymphoma, T-Cell, Cutaneous 31Leukemia, Biphenotypic, Acute 29Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28Leukemia, B-Cell 27Lymphoma, Large-Cell, Anaplastic 26Mycosis Fungoides 25Sarcoma 24Lymphoproliferative Disorders 21

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chromosome 7, monosomy × Lymphoid × 90 days × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡